Iterative design-build-test-learn cycles to engineer Bacillus subtilis for enhanced production of target compounds.
Our service covers the complete pathway optimization workflow: in silico modeling, gene synthesis, strain construction, cultivation, and metabolite quantification—all under a single project manager. Each project is tailored to the target molecule and includes iterative rounds of optimization.
We apply a structured design-build-test-learn methodology tailored to your target molecule and production goals. Each project begins with in silico pathway design and progresses through iterative cycles of genetic engineering and fermentation evaluation.
Retrosynthetic analysis and flux balance modeling to identify optimal gene combinations and regulatory nodes for the target product.
Iterative rounds of DNA assembly, transformation, and shake-flask screening to identify high-producing variants.
Design and assemble biosynthetic gene clusters or individual pathway modules tailored to B. subtilis codon usage and regulatory context.
Optimization of media composition, induction conditions, and feeding strategy to evaluate yield and productivity.
HPLC and LC-MS quantification of target metabolite and key intermediates, with optional byproduct profiling.
Each project delivers a clearly documented engineered B. subtilis strain alongside quantitative performance data and standard operating procedures.
Projects are scoped per target molecule and project-scoped attributes assessed analytically. Below are typical parameters discussed during initial consultation.
| Parameter | Typical project scope |
|---|---|
| Target Molecule Class | Small molecules, amino acids, organic acids, polyketides, peptides, or heterologous proteins |
| Pathway Design Strategy | Retrosynthetic modeling, heterologous pathway assembly, or existing pathway optimization |
| Genetic Modification Approach | Plasmid-based expression, chromosomal integration, promoter engineering, or gene knockouts |
| Evaluation Scale | Shake-flask (scale scoped per project–scale scoped per project) to bench-top bioreactor (scale |
| Quantification Method | HPLC-UV/RI, LC-MS/MS, or bioassay for target metabolite; byproduct profile as needed |
| Number of Improvement Cycles | Determined per project; typically 3–5 iterative rounds with interim data review |
Our standard workflow follows five phases from initial design to final strain validation.
We perform retrosynthetic analysis and flux balance modeling to select enzyme candidates and design synthetic operons. Target molecule pathways are mapped using B. subtilis genome-scale models to identify flux bottlenecks.
Custom DNA fragments are synthesized and assembled into B. subtilis expression vectors with appropriate promoters, RBS, and terminators. Constructs are sequence-verified before transformation.
Competent B. subtilis cells are transformed with the pathway plasmids. Positive clones are selected on antibiotics and confirmed by colony PCR and sequencing.
Multiple clones are cultivated in shake flasks under controlled conditions. Optical density and metabolite concentrations are monitored to rank production performance.
Culture supernatants are analyzed by HPLC or LC-MS for target and intermediate quantification. Top-performing strains are selected for the next round of engineering or final characterization.
Our service supports a wide range of industrial biotechnology applications where B. subtilis is a preferred host.
Engineer B. subtilis for high-yield production of lactic acid, succinic acid, butanol, and other platform chemicals using renewable feedstocks.
Evaluate secretion pathways and expression systems in B. subtilis for industrial enzymes, therapeutic proteins, or diagnostic reagents.
Reconstitute and evaluate biosynthetic gene clusters from actinomycetes or fungi in B. subtilis for novel natural product discovery and production.
Common questions about our Bacillus subtilis pathway optimization service.
We work with a broad range of product classes including organic acids, amino acids, polyketides, terpenoids, and heterologous proteins. The pathway complexity is evaluated during initial consultation to investigate feasibility and scoping.
The number of design-build-test-learn cycles is project-dependent, typically ranging from two to five rounds depending on pathway complexity and target yield. Interim milestones are defined at project start to assess progress and decide on additional cycles.
Yes, we can use customer-provided strains as starting hosts. Alternatively, we offer common laboratory strains optimized for transformation and protein secretion. All work is performed under a material transfer agreement to protect your IP.
Project timelines are determined during scoping and depend on the number of engineering cycles, pathway length, and analytical requirements. A typical single-cycle project may take a timeline confirmed during project scoping, while multi-cycle projects can extend to a timeline confirmed during project scoping. We provide a detailed timeline with milestones at the proposal stage.
Get a customized quote for your Accelerate Production Strain Development from Pathway Design to Pre-Pilot Scale. project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.